BCIQ Profiles

Company Profile Report

Shire evaluating neurology pipeline

In its 2Q17 earnings report, Shire plc (LSE:SHP; NASDAQ:SHPG) said it will evaluate options for its neurology franchise, with the potential of spinning out the company’s core ADHD business into an

Read the full 314 word article

How to gain access

Continue reading with a
two-week free trial.